Home Cart Sign in  
Chemical Structure| 867162-37-6 Chemical Structure| 867162-37-6

Structure of 867162-37-6

Chemical Structure| 867162-37-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 867162-37-6 ]

CAS No. :867162-37-6
Formula : C20H15ClN4
M.W : 346.81
SMILES Code : NC(C1=NC=CN=C1Cl)C2=CC=C3C=CC(C4=CC=CC=C4)=NC3=C2

Safety of [ 867162-37-6 ]

Application In Synthesis of [ 867162-37-6 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 867162-37-6 ]

[ 867162-37-6 ] Synthesis Path-Downstream   1~2

  • 1
  • [ 867162-37-6 ]
  • [ 63845-28-3 ]
  • [ 867162-98-9 ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In dichloromethane; at 20℃; for 16.0h; (4-({ [(3-Chloro-pyrazin-2-yl)-(2-phenyl-quinolin-7-yl)-methyl]-carbamoyl}-methyl)- piperidine-1-carboxylic acid benzyl ester); [1123] (3-Chloropyrazin-2-yl)(2-phenylquinolin-7-yl)-methanamine (120.00 mg, 0.35 mmol), EDC (100.64 mg, 0.53 mmol) and HOBt (47.29 mg, 0.35 mmol) were suspended in CH2C12 (2 mL) and charge with DIEA (122.00 muL, 0.70 mmol) followed by the addition of 1- N-Cbz-4-piperidineacetic acid (127.56 mg, 0.46 mmol). The reaction mixture was stirred at rt for 16 h. The reaction mixture was diluted with CH2Cl2 (10 mL) and washed with saturated NaHC03 (2 x 20 mL) and brine (2 x 20 mL). The organic layer was dried over Na2S04 and concentrated in vacuo. The crude product was purified by a 10 g Jones silica gel (wetted with 50% EtOAc/ Hexane, dried loaded onto silica, and run with 60% EtOAc/ Hexanes - 70% EtOAc/ Hexanes) affording the desired product; ¹H NMR (400 MHz, CHLOROFORM-d) 8 8.56 (1 H, d, J=2.47), 8.39 (1 H, d, J= 2.50), 8.23 (1 H, d, J= 4.77), 8.11 (2 H, d, J= 7.06), 7.85 (3 H, dd, J= 8.60, J= 8.38), 7.74 (1 H, s), 7.50 (3H, m), 7.32 (6H, m), 6.78 (1 H, d, J= 7.76), 5.10 (2 H, s), 4.11 (2 H, m), 2.75 (2 H, m), 2.21 (2 H, d, J= 7.00), 2.01 (1 H, m), 1.67 (2 H, m), 1.15 (2 H, d, J= 8.921) ; MS (ES+): m/z 605.96/606.98/608.93 (100/40/15) [MH(at)] ; HPLC: tR = 3.33 min. (OpenLynx, nonpolar_5min.).
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; N-ethyl-N,N-diisopropylamine; In dichloromethane; at 20℃; for 16.0h; (3-Chloropyrazin-2-yl)(2-phenylquinolin-7-yl)-methanamine (120.00 mg, 0.35 mmol), EDC (100.64 mg, 0.53 mmol) and HOBt (47.29 mg, 0.35 mmol) were suspended in CH2Cl2 use CH2C12(2 mL) and charge with DIEA (122.00 muL, 0.70 mmol) followed by the addition of l-JV-Cbz-4-piperidineacetic acid (127.56 mg, 0.46 mmol). The reaction mixture was stirred at rt for 16 h. The reaction mixture was diluted with CH2Cl2 (10 mL) and washed with saturated NaHCO3 (2 x 20 mL) and brine (2 x 20 mL). The organic layer was dried over Na2SO4 and concentrated in vacuo. The crude product was purified by a 10 g Jones silica gel (wetted with 50% EtOAc / Hexane, dried loaded onto silica, and run with 60% EtOAc / Hexanes - > 70% EtOAc / Hexanes). The product was evaporated in vacuo which afforded the title compound; 1H NMR (400 MHz, CHLOROFORM-d) delta 8.56 (1 H, d, J=IAT), 8.39 (1 H, d, J= 2.50), 8.23 (1 H, d, J= 4.77), 8.11 (2 H, d, J= 7.06), 7.85 (3 H, dd, J= 8.60, J= 8.38), 7.74 (1 H, s), 7.50 (3H, m), 7.32 (6H, m), 6.78 (1 H, d, J= 7.76), 5.10 (2 H, s), 4.11 (2 H, m), 2.75 (2 H, m), 2.21 (2 H, d, J= 7.00), 2.01 (1 H, m), 1.67 (2 H, m), 1.15 (2 H, d, J= 8.921); MS (ES+): m/z 605.96/606.98/608.93 (100/40/15) [MH+]; HPLC: tR = 3.33 min. (OpenLynx, nonpolar_5min.).
  • 2
  • [ 867162-37-6 ]
  • [ 15760-36-8 ]
  • [ 867163-52-8 ]
YieldReaction ConditionsOperation in experiment
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; for 24h; 3-Methylenecyclobutanecarboxylic acid [(3-chloropyrazin-2-yl)-(2-phenyl-quinolin-7- yl)-methyl]-amide; [1196] C-(3-Chloro-pyrazin-2-yl)-C-(2-phenylquinolin-7-yl)-methylamine (690mg, 1.99mmol) was dissolved in 6.0mL of CH2C12 followed by the addition of EDC (600mg, 2.98mmol) and HOBT (300mg, 1.99mmol). 3-Methylenecyclobutanecarboxylic acid (300mg, 2.59mmol) was dissolved in l.OmL of CH2Cl2 and added to the homogenous reaction mixture. After 24h the reaction was concentrated in vacuo and dissolved in EtOAc and the organic layer was washed with sat. NaHC03. The organic layer was washed with H20 and brine. The organic layers where combined, dried over sodium sulfate, filtered and concentrated in vacuo. The crude product was purified by silica gel column chromatography [Jones Flashmaster, l Og cartridge, eluting with 50% EtOAc: Hex] to obtain the desired product as a white fluffy solid; ¹H NMR (400MHz, CDC13): No. = 2.82-2.92 (m, 2H), 2.99- 3.06 (m, 2H), 4.77-4.80 (m, 2H), 6.81 (d, 1H, J= 7.8 Hz), 7.45-7.54 (m, 3H), 7.83-7.88 (m, 3H), 8.10 (d, 2H, J= 7.1 Hz), 8.22-8.23 (brm, 1H), 8.39 (d, 1H, J= 1.79 Hz), 8.59 (d, 1H, J = 2.5 Hz) ; MS (ES+): 440.93 (M+1), 442.91 (M+3).
With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; In dichloromethane; for 24h; C-(3-Chloro-pyrazin-2-yl)-C-(2-phenylquinolin-7-yl)-methylamine (690mg, 1.99mmol) was dissolved in 6.OmL Of CH2Cl2 followed by the addition of EDC (600mg, 2.98mmol) and HOBT (300mg, 1.99mmol). 3-Methylenecyclobutanecarboxylic acid (300mg, 2.59mmol) was dissolved in 1.OmL Of CH2Cl2 and added to the homogenous reaction mixture. After 24h the reaction was concentrated in vacuo and dissolved in EtOAc and the organic layer was washed with sat. NaHCO3. The organic layer was washed with H2O and brine. The organic layers where combined, dried over sodium sulfate, filtered and concentrated in vacuo. The crude product was purified by silica gel column chromatography [Jones Flashmaster, 1Og cartridge, eluting with 50% EtOAc: Hex] to obtain the desired product as a white fluffy solid; 1H NMR (400MHz, CDCl3): δ = 2.82-2.92 (m, 2H), 2.99-3.06 (m, 2H), 4.77-4.80 (m, 2H), 6.81 (d, IH, J= 7.8 Hz), 7.45-7.54 (m, 3H), 7.83-7.88 (m, 3H), 8.10 (d, 2H, J= 7.1 Hz), 8.22-8.23 (brm, IH), 8.39 (d, IH, J= 1.79 Hz), 8.59 (d, IH, J= 2.5 Hz); MS (ES+): 440.93 (M+l), 442.91 (M+3).
 

Historical Records